Effects of Cigarette Smoke on The Immune System

  • Slides: 33
Download presentation
Effects of Cigarette Smoke on The Immune System Chiung-Zuei Chen MD Department of Internal

Effects of Cigarette Smoke on The Immune System Chiung-Zuei Chen MD Department of Internal Medicine National Cheng Kung University Hospital

n n Cigarette Smoking and Infection Effects of Cigarette Smoke on The Immune System

n n Cigarette Smoking and Infection Effects of Cigarette Smoke on The Immune System Macrophage and Innate Immunity- Scavenger Receptor MARCO The Effects of Cigarette Smoke Extract on MARCO Expression and Mp clearance by THP-1 Cells

Cigarette Smoking and Infection Cigarette Smoking and Invasive Pneumococcal Disease n Population-based Case-Control study

Cigarette Smoking and Infection Cigarette Smoking and Invasive Pneumococcal Disease n Population-based Case-Control study Healthy young and middle-aged adults 18~64 years of age 228 patients vs 301 control n N Engl J Med 2000; 342: 681 -9

Cigarette Smoking and Infection n Independent Risk Factors for Invasive Pneumococcal Disease among Immunocompetent

Cigarette Smoking and Infection n Independent Risk Factors for Invasive Pneumococcal Disease among Immunocompetent Adults 18 to 64 Years Old Variable ODDs Ratio P value Male 2. 7(1. 7 -4. 3) <0. 001 Black Race 3. 4(2. 0 -5. 6) <0. 001 Chronic illness 2. 6(1. 4 -5. 1) 0. 005 Current Smoker 4. 1(2. 4 -7. 3) <0. 001 Passive exposure 2. 5(1. 2 -5. 1) 0. 01 Children household 3. 0(1. 5 -6. 2) 0. 003 Smoking status N Engl J Med 2000; 342: 681 -9

Cigarette Smoking and Infection n Dose-Response Relations N Engl J Med 2000; 342: 681

Cigarette Smoking and Infection n Dose-Response Relations N Engl J Med 2000; 342: 681 -9 Variable ODDs Ratio P value No. of cigarette smoked reference Adjusted for multiple variables 1 -14/day 2. 3(1. 3 -4. 3) 0. 006 15 -24/day 3. 7(1. 8 -7. 8) <0. 001 >25/day 5. 5(2. 5 -12. 9) <0. 001

Cigarette Smoking and Infection Cigarette Smoking as a Risk Factor for Epidemic A(H 1

Cigarette Smoking and Infection Cigarette Smoking as a Risk Factor for Epidemic A(H 1 N 1) Influenza in Young Men n 336 healthy young male recruits in the Israeli military unit n Incidence 68% (smoker) vs 47. 2% (Non-smoker) OR: 2. 42 (1. 53 -3. 83) p<0. 001 N Engl J Med 1982; 307: 1042 -6

Cigarette Smoking and Infection Rate of severe Influenza Light-smoker (up to 10/day) Moderate (11

Cigarette Smoking and Infection Rate of severe Influenza Light-smoker (up to 10/day) Moderate (11 -20/day) Heavy-smoker (>20/day) No(%) ODDs Ratio Nonsmoker 49(30. 1) 1. 00 Light. Smoker 15(42. 9) 1. 74 Moderate 32(51. 6) 2. 48 -Smoker N Engl J Med 1982; 307: 1042 -6 Heavy. Smoker 38(53. 5) 2. 68

Cigarette Smoking and Infection Smoking and Mortality from Tuberculosis and Other Disease in India

Cigarette Smoking and Infection Smoking and Mortality from Tuberculosis and Other Disease in India n Large case-control study/ Mortality at age 2569 years n Retrospective study of 43000 adult male death and 35000 controls Lancet 2003; 362: 507 -15

Cigarette Smoking and Infection Smoking and Mortality from Tuberculosis and Other Disease in India

Cigarette Smoking and Infection Smoking and Mortality from Tuberculosis and Other Disease in India n Prevalence risk ratio of tuberculosis was 2. 9(2. 6 -3. 3) for ever-smokers vs never smokers n Risk ratio of tuberculosis death was for ever-smokers vs never smokers 4. 5 (4. 0 -4. 5) and 4. 2(3. 7 -4. 8) for urban & rural residents Lancet 2003; 362: 507 -15

Effects of Cigarette Smoke on the Immune System Impact of Cigarette Smoke on Clearance

Effects of Cigarette Smoke on the Immune System Impact of Cigarette Smoke on Clearance and Inflammation after Pseudomonas aeruginosa Infection n C 57 BL/6 Mice n 1 R 1 or 1 R 3 reference cigarette daily (5 days per week for 6 -8 weeks) Am J Respir Crit Care 2004; 170: 1164 -1171

Impact of Cigarette Smoke on Clearance and Inflammation after Pseudomonas aeruginosa Infection Delayed rate

Impact of Cigarette Smoke on Clearance and Inflammation after Pseudomonas aeruginosa Infection Delayed rate of bacterial clearance after 4 & 12 Hrs bacterial inoculation in smoke-exposed for 68 weeks mice * P<0. 05 n * * * Am J Respir Crit Care 2004; 170: 1164 -1171

Immunotoxicology of Cigarette Smoke Condensates: Suppression of Macrophage Responsiveness to Interferon γ C 57

Immunotoxicology of Cigarette Smoke Condensates: Suppression of Macrophage Responsiveness to Interferon γ C 57 BL/6 mice treat with CSC-MS n Short-term exposure culture murine peritoneal macrophages as a model n Toxicol Appl Pharmacol 1998; 149: 136 -143

Immunotoxicology of Cigarette Smoke Condensates: Suppression of Macrophage Responsiveness to Interferon γ n CSC-MS

Immunotoxicology of Cigarette Smoke Condensates: Suppression of Macrophage Responsiveness to Interferon γ n CSC-MS inhibited increase in phagocytosis in response to Interferon -γover 18 Hrs % phagocytosis 35 35 [CSC-MS]% 0 0. 04 0. 06 30 25 20 0. 08 0. 1 Toxicol Appl Pharmacol 1998; 149: 136143

Immunotoxicology of Cigarette Smoke Condensates: Suppression of Macrophage Responsiveness to Interferon -γ n CSC-MS

Immunotoxicology of Cigarette Smoke Condensates: Suppression of Macrophage Responsiveness to Interferon -γ n CSC-MS enhanced TNF -α production in response to LPS over 18 Hrs (0 vs 0. 05 vs 0. 1% CSC-MS) 0 Toxicol Appl Pharmacol 1998; 149: 136 -143

Cigarette Smoke & Phagocyte Function: Effect of Chronic Exposure in Vivo & Acute Exposure

Cigarette Smoke & Phagocyte Function: Effect of Chronic Exposure in Vivo & Acute Exposure in Vitro n Phagocytosis Activity (30 Minutes & 24 Hours) 100. 0+2. 1 (control) vs 21. 8+0. 96 (smoke) p<0. 05 100. 0+4. 0 (control) vs 28. 6+3. 5 (smoke) p<0. 05 Infection & Immunity 1978; 20: 468 -475

Macrophage & Innate Immunity n n 1. 2. A first line of defense against

Macrophage & Innate Immunity n n 1. 2. A first line of defense against microbial invaders To distinguish dangerous non-self materials from self-molecules; Pattern Recognition Receptors Non-phagocytic : Toll-like receptor Phagocytic : Scavenger receptor

Macrophage & Innate Immunity n n 1. 2. 3. MARCO MAcrophage Scavenger Receptor with

Macrophage & Innate Immunity n n 1. 2. 3. MARCO MAcrophage Scavenger Receptor with COllagenous Structure SR-A Restricted to subpopulations of macrophage Bind a range of G(-) & G(+) bacterial & environmental particles

MAcrophage Scavenger Receptor with COllagenous structure

MAcrophage Scavenger Receptor with COllagenous structure

The Scavenger Receptor MARCO is Required for Lung Defense against Pneumococcal pneumonia & Inhaled

The Scavenger Receptor MARCO is Required for Lung Defense against Pneumococcal pneumonia & Inhaled Particles n n MARCO-/- vs C 57 BL/6 wild type mice Intranasal instillation Pneumococcal pneumonia 4 & 24 Hrs J Exp Med 2004; 200: 267 -272

The Scavenger Receptor MARCO is Required for Lung Defense against Pneumococcal pneumonia & Inhaled

The Scavenger Receptor MARCO is Required for Lung Defense against Pneumococcal pneumonia & Inhaled Particles n n MARCO-/- mice displaced an impaired ability to clear bacteria from the lungs ~8% (MARCO+/+) vs >50% (MARCO-/-) J Exp Med 2004; 200: 267 -272

The Scavenger Receptor MARCO is Required for Lung Defense against Pneumococcal pneumonia & Inhaled

The Scavenger Receptor MARCO is Required for Lung Defense against Pneumococcal pneumonia & Inhaled Particles MARCO-/- mice increased pulmonary inflammation & cytokine release More neutrophils 17+7. 40 (MARCO-/-) vs 2. 45+0. 46% (MARCO+/+) n TNF-α & MIP-2 0. 58+0. 14 (MARCO-/-) vs 0. 13+0. 01 (MARCO+/+) n J Exp Med 2004; 200: 267 -272

The Scavenger Receptor MARCO is Required for Lung Defense against Pneumococcal pneumonia & Inhaled

The Scavenger Receptor MARCO is Required for Lung Defense against Pneumococcal pneumonia & Inhaled Particles MARCO-/- mice diminished survival Mortality: 100% (MARCO-/-) vs 40% (MARCO+/+) n n In vitro phagocytosis ability was dramatically impaired J Exp Med 2004; 200: 267 -272

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived Macrophages Introduction (I) n Mycoplasma pneunoniae (Mp) plays an important role in the acute exacerbation of COPD n Lung macrophages are the first line of defense against infection or inhaled agents

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived Macrophages Introduction (II) n Acute exposure to cigarette smoke (CS) has been shown to inhibit the bactercidal activity of alveolar macrophage for Pseudomonas aeruginosa n The mechanisms involved in CS-induced inhibition of macrophage phagocytosis are still unknown

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived Macrophages Introduction (III) n MARCO contributes to macrophage phagocytosis of typical bacteria Hypothesis n We hypothesize that CS decreases macrophage’s MARCO expression thus impairing phagocytosis of bacteria (e. g. Mp)

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived Macrophages Methods n Human THP-1 derived macrophages were used as a model to test the effect of acute (6 Hr) CSE exposure (5%, 10% and 20%) on MARCO m. RNA (Real Time RT-PCR) and Protein (Western Blotting) expression (n=5)

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived Macrophages 30+11% (p=0. 06) 36+8% (p=0. 01) 46+13% (p=0. 03)

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived Macrophages Methods n The effects of MARCO on Mp clearance by macrophages were assessed (n=3) n After a 6 Hr CSE, macrophages were infected with Mp (1 CFU/cell) for 2 Hrs n Supernatants and monolayer of macrophages were collectede for total Mp counting

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived Macrophages A 6 Hr exposure 20% CSE increased total Mp count by 27% 74+0. 6 vs 58+2. 2 10000 CFU/ml P=0. 046

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived Macrophages Methods n The effects of MARCO on Mp clearance by macrophages were tested using a MARCOneutralizing Ab (0. 002, 0. 02 and 0. 2 μg/ml) at 1 Hr prior to Mp (1 CFU/cell) n=4

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived Macrophages 17+4. 9% (p=0. 07) 29+4. 9% (p=0. 03) 30+2. 1% (p=0. 005)

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived

The Effects of CSE on MARCO Expression and Mp Clearance by Human THP-1 derived Macrophages Conclusion n Acute exposure of CSE caused a reduction of MARCO expression and Mp clearance by macrophages n CSE-induced reduction of Mp clearance by macrophages may be partially through the down-regulation of MARCO expression

THANK YOU

THANK YOU